814PPlatinum-based therapy in men with metastatic castration resistant prostate (mCRPC) with or without DNA repair defects: A multicentre retrospective analysis. (23rd October 2018) - Gillessen, S; Schmid, S; Beltran, H; Almeida, D V P; Mehra, N; Lavaud, P; Morales Barrera, R; Pignataro, D; Castro Marcos, E; Conteduca, V; Efstathiou, E; Le, H M L; et al.